Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HYH9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 4 | 6 | PF00675 | 0.497 |
CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.497 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.534 |
DEG_SPOP_SBC_1 | 37 | 41 | PF00917 | 0.650 |
DOC_MAPK_DCC_7 | 30 | 38 | PF00069 | 0.552 |
DOC_MAPK_MEF2A_6 | 30 | 38 | PF00069 | 0.512 |
DOC_PP4_MxPP_1 | 31 | 34 | PF00568 | 0.611 |
DOC_USP7_MATH_1 | 52 | 56 | PF00917 | 0.568 |
DOC_WW_Pin1_4 | 21 | 26 | PF00397 | 0.516 |
DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.561 |
LIG_14-3-3_CanoR_1 | 19 | 25 | PF00244 | 0.429 |
LIG_14-3-3_CanoR_1 | 4 | 13 | PF00244 | 0.461 |
LIG_14-3-3_CanoR_1 | 96 | 105 | PF00244 | 0.501 |
LIG_Actin_WH2_2 | 81 | 98 | PF00022 | 0.547 |
LIG_FHA_1 | 102 | 108 | PF00498 | 0.399 |
LIG_FHA_1 | 37 | 43 | PF00498 | 0.648 |
LIG_FHA_1 | 78 | 84 | PF00498 | 0.529 |
LIG_FHA_1 | 90 | 96 | PF00498 | 0.468 |
LIG_LIR_Gen_1 | 104 | 113 | PF02991 | 0.491 |
LIG_LIR_Gen_1 | 50 | 58 | PF02991 | 0.638 |
LIG_LIR_Nem_3 | 104 | 108 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 50 | 56 | PF02991 | 0.640 |
LIG_MYND_1 | 33 | 37 | PF01753 | 0.621 |
LIG_NRBOX | 72 | 78 | PF00104 | 0.604 |
LIG_SH2_CRK | 105 | 109 | PF00017 | 0.494 |
LIG_SH2_CRK | 17 | 21 | PF00017 | 0.494 |
LIG_SH2_STAP1 | 105 | 109 | PF00017 | 0.520 |
LIG_SH3_3 | 31 | 37 | PF00018 | 0.548 |
LIG_SUMO_SIM_anti_2 | 106 | 112 | PF11976 | 0.553 |
LIG_SUMO_SIM_par_1 | 106 | 112 | PF11976 | 0.562 |
MOD_CK1_1 | 47 | 53 | PF00069 | 0.644 |
MOD_Cter_Amidation | 2 | 5 | PF01082 | 0.573 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.622 |
MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.482 |
MOD_GSK3_1 | 38 | 45 | PF00069 | 0.574 |
MOD_NEK2_1 | 109 | 114 | PF00069 | 0.556 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.469 |
MOD_Plk_4 | 103 | 109 | PF00069 | 0.361 |
MOD_Plk_4 | 52 | 58 | PF00069 | 0.634 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.558 |
MOD_Plk_4 | 89 | 95 | PF00069 | 0.392 |
MOD_ProDKin_1 | 21 | 27 | PF00069 | 0.515 |
MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.561 |
TRG_ENDOCYTIC_2 | 105 | 108 | PF00928 | 0.450 |
TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.464 |
TRG_ER_diArg_1 | 4 | 6 | PF00400 | 0.497 |
TRG_Pf-PMV_PEXEL_1 | 96 | 100 | PF00026 | 0.467 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I123 | Leptomonas seymouri | 69% | 100% |
A0A0S4IR74 | Bodo saltans | 35% | 70% |
A0A0S4KIC6 | Bodo saltans | 43% | 100% |
A0A1X0P673 | Trypanosomatidae | 53% | 100% |
A0A1X0P697 | Trypanosomatidae | 41% | 91% |
A0A3Q8IBJ2 | Leishmania donovani | 100% | 100% |
A0A422NUP2 | Trypanosoma rangeli | 49% | 100% |
A4HA99 | Leishmania braziliensis | 81% | 100% |
D0A0V3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 91% |
E9ASA3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q4QD59 | Leishmania major | 97% | 100% |